09.11.2021 • News

Trinseo Explores Sales of Styrenics Business

US plastics and rubber producer Trinseo has announced that it has started exploring the sale of its styrenics businesses. The company plans to launch a formal sales process in the first quarter of 2022, which it expects will include the feedstocks and polystyrene units, as well as its 50% share in Americas Styrenics, a joint venture with Chevron Phillips Chemical.

The proposed move follows Trinseo’s agreement in May to sell its synthetic rubber business based in Schkopau, Germany, to Poland’s Synthos for $491 million.

The businesses concerned – including the share of Americas Styrenics – generated $153.5 million in adjusted EBITDA in 2020. Trinseo’s other business units are latex binders, engineering materials and base plastics.

“The separation of the styrenics businesses would represent another key step in our transformation toward becoming a specialty materials and sustainable solutions provider,” said CEO Frank Bozich. “We will continue to prioritize investments in higher growth, higher margin and lower earnings volatility areas such as engineered materials and CASE (coatings, adhesives, sealants and elastomers) with an ongoing focus on sustainability, including the continued decrease in our CO2 intensity through various initiatives including the transformation of our portfolio.”

Author: Elaine Burridge, Freelance Journalist

Trinseo has started exploring the sale of its styrenics businesses. The company...
Trinseo has started exploring the sale of its styrenics businesses. The company plans to launch a formal sales process in Q1 2022, expected to include the feedstocks and polystyrene units, as well as its 50% share in Americas Styrenics, a joint venture with Chevron Phillips. (c) Trinseo

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read